Fetal Growth Retardation: all 268 studies

Page 3 of 3. Open to participants first (67), then studies with results posted, then the rest; newest registration first within each.

• Assessing the Feasibility of Integrating Maternal Nutrition Interventions Into an Existing MNCH Platform in BangladeshCompletedNCT02745249Not applicable
• The Effect of Omega 3 on Pregnancy Complicated by Asymmetrical Intrauterine Growth RestrictionCompletedNCT02696577Phase 2
• The Possible Effect Of Amniotic Fluid pH On Neonatal Morbidities In Maternal Inflammation/Infection Associated PregnanciesCompletedNCT02691559Not applicable
• Sildenafil Citrate for the Management of Asymmetrical Intrauterine Growth RestrictionStatus unknownNCT02678221Phase 2
• Low-molecular-weight Heparin in Constituted Vascular Intrauterine Growth RestrictionCompletedNCT02672566Phase 3
• Intraumbilical Amino Acids and Glucose Supplementation Via Port by Severe IUGR in Human FetusesCompletedNCT02596594Not applicable
• A Trial Evaluating the Role of Sildenafil in the Treatment of Fetal Growth RestrictionCompletedNCT02590536Phase 3
• Dextrose Gel Does Not Prevent Neonatal HypoglycemiaCompletedNCT02523222Phase 2/3
• Evaluation of Infants With Intrauterine Growth RestrictionStatus unknownNCT02515292
• Sildenafil Therapy In Dismal Prognosis Early-Onset Intrauterine Growth RestrictionTerminatedNCT02442492Phase 2/3
• Role of Ginkgo Biloba Extract in IUGRCompletedNCT02425436Phase 2
• Pre-Eclampsia And Growth Restriction: a Longitudinal StudyCompletedNCT02379832
• First Trimester Prediction of Preeclampsia and Fetal Growth RestrictionCompletedNCT02379494
• A Randomized Trial of Docosahexaenoic Acid Supplementation During Pregnancy to Prevent Deep Placentation DisordersStatus unknownNCT02336243Phase 3
• Effect of Low Dose Aspirin on Birthweight in Twins: The GAP Trial.CompletedNCT02280031Phase 2
• The Dutch STRIDER (Sildenafil TheRapy In Dismal Prognosis Early-onset Fetal Growth Restriction)TerminatedNCT02277132Phase 2/3
• Maternal Serum Vascular Endothelial Growth Factor in Pregnant Women With Foetal Growth RestrictionStatus unknownNCT02245477
• Evaluation of Fetoplacental Oxygenation With Functional MRI in Pregnant WomenCompletedNCT02238301Not applicable
• Fish Oil Trials in Pregnancy for the Prevention of Pregnancy Complications ('FOTIP')CompletedNCT02229526Not applicable
• Craniofacial Microsomia: Longitudinal Outcomes in Children Pre-Kindergarten (CLOCK)CompletedNCT02224677
• First-trimester Prediction of PreeclampsiaCompletedNCT02189148
• EVERREST Developing a Therapy for Fetal Growth RestrictionCompletedNCT02097667
• Antenatal Detection of Fetal Growth Restriction and Stillbirths Rate.Status unknownNCT01995968
• A Cluster-Randomized Trial of Ultrasound Use to Improve Pregnancy Outcomes in Low Income Country SettingsCompletedNCT01990625Not applicable
• Prediction of Growth Restricted Fetuses Using Femur Length to Mid-thigh Circumference Ratio: A Case-control StudyStatus unknownNCT01981824
• Obesity and Oral Contraceptive FailureTerminatedNCT01944306
• Influence of Intrauterine Growth Restriction on Amplitude-integrated EEG in Preterm InfantsStatus unknownNCT01942525
• A Randomized Air Filter Intervention Study of Air Pollution and Fetal Growth in a Highly Polluted CommunityCompletedNCT01741051Not applicable
• Long Term Effect of Somatropin in Subjects With Intrauterine Growth RetardationCompletedNCT01734447Phase 4
• Growth Hormone Treatment of Children Diagnosed of Intrauterine Growth RetardationCompletedNCT01697644Phase 4
• Melatonin to Prevent Brain Injury in Unborn Growth Restricted BabiesCompletedNCT01695070Phase 4
• Clinical Trial of Fat Grafts Supplemented With Adipose-derived Regenerative CellsCompletedNCT01674439Phase 2
• Impact of Pre-pregnancy Micronutrient Supplementation on Maternal and Child OutcomesCompletedNCT01665378Not applicable
• A Modernized Approach to Prenatal Care in Low Risk WomenCompletedNCT01606774Not applicable
• Routine Ultrasound Screening in the Third TrimesterCompletedNCT01594463Not applicable
• Antiphospholipid Antibodies and Fetal Growth RestrictionStatus unknownNCT01538134
• Progesterone for First Trimester Vaginal BleedingWithdrawnNCT01501890Not applicable
• Prediction of Low Birth Weight Infants Using Ultrasound Measurement of Placental Diameter and ThicknessStatus unknownNCT01501851
• Can Low Molecular Weight Heparin During Pregnancy With Intrauterine Growth Restriction Increase Birth Weight?CompletedNCT01390051Phase 4
• The NICHD Fetal Growth Study: Twin GestationsCompletedNCT01369940
• Comparison of Doses of Acetylsalicylic Acid in Women With Previous History of PreeclampsiaCompletedNCT01352234Phase 4
• Sonographic Differences in Brain Measurements Between Normal and Intrauterine Growth Restriction (IUGR) FetusesWithdrawnNCT01178619
• The Role of Pro-angiogenic Immune Cells in Human PregnanciesStatus unknownNCT01177020
• Sildenafil and Uteroplacental PerfusionStatus unknownNCT01107782Phase 2/3
• Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy OutcomeCompletedNCT01068795Not applicable
• Observational Study in UTERO - Placental 3D Doppler Examination: Interest for Pre-eclampsia Screening During PregnancyCompletedNCT00930397
• Severe Intrauterine Growth Retardation: Developmental Newborn Intensive Care Unit (NICU) CareCompletedNCT00914108Not applicable
• Effect of Prenatal Nutritional Supplementation on Birth Outcome in Hounde District, Burkina FasoCompletedNCT00909974Phase 4
• Is Serum YKL-40 Capable of Predicting Intrauterine Growth Restriction (IUGR) and Preeclampsia?Status unknownNCT00836524
• Impact of Maternal Pomegranate Juice on Brain Injury in Infants With Intrauterine Growth Restriction (IUGR)CompletedNCT00788866Not applicable
• MorbiMortality Amelioration in Preeclamptic Primiparas Study. MoMA Pre Prim StudyCompletedNCT00763672Not applicable
• Low-Dose Aspirin in in Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI) TreatmentsCompletedNCT00683202Not applicable
• Prevention of Intrauterine Growth Retardation in Burkina Faso: the Malaria ComponentCompletedNCT00680732Phase 4
• Prevention of Intrauterine Growth Retardation in Hounde District, Burkina FasoCompletedNCT00642408Phase 4
• Severe Pregnancy Complications Are Associated With Elevated Factor VIII Plasma ActivityStatus unknownNCT00573118
• L-Arginine Treatment for Severe Vascular Fetal Intrauterine Growth Restriction: a Randomized Double Bind Controlled Trial (L Arginine in IUGR)TerminatedNCT00549575Phase 3
• Epigenetic Markers in Growth Restricted Human Pregnancies: a Case-controlled StudyCompletedNCT00510380
• Doppler and Biological Second Trimester Placental Insufficiency ScreeningCompletedNCT00465634
• MAXOMAT ® in the Treatment of Severe Early Onset Intrauterine Growth Retardation on Pre-pubertal ChildrenCompletedNCT00452491Phase 3
• Viagra for the Treatment of IUGRStatus unknownNCT00347867Phase 4
• Antenatal Allopurinol in Intrauterine Growth RestrictionStatus unknownNCT00346463Not applicable
• LMWH to Prevent Preeclampsia and Fetal Growth RestrictionTerminatedNCT00260520
• Fetal Growth Restriction & Maternal Cardiovascular RiskCompletedNCT00241683
• Antepartum Chronic Epidural Therapy (ACET) to Improve Blood Flow to the Uterus, Placenta and Baby in Pre-Eclampsia and Intrauterine Growth RestrictionCompletedNCT00197340Phase 3
• Preterm Fetal Growth Restriction and Developmental CareStatus unknownNCT00166660Phase 2
• Amniotic Fluid Tandem Mass Spectrometry for Pregnancies Complicated by NIH and Severe Symmetrical IUGRTerminatedNCT00143039
• Study to Examine Insulin Resistance During Growth Hormone Treatment for Short Stature Due to Low BirthweightStatus unknownNCT00120497
• Genetic Study of Insulin-Like Growth Factor-I Receptor Mutations in Patients With Intrauterine Growth RetardationStatus unknownNCT00005105

← Fetal Growth Retardation overview